Koschny, Ronald <br/><br/>
Diarrhea is a positive outcome predictor for sorafenib treatment of advanced hepatocellular carcinoma.  [electronic resource] 

 -  Oncology  2013 
 - 6-13 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1423-0232 
<br/><br/><label>Standard No.: </label>10.1159/000342425  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Benzenesulfonates--therapeutic use<br/>Carcinoma, Hepatocellular--complications<br/>Diarrhea--chemically induced<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Liver Cirrhosis--complications<br/>Liver Neoplasms--complications<br/>Male<br/>Middle Aged<br/>Nausea--chemically induced<br/>Niacinamide--analogs & derivatives<br/>Phenylurea Compounds<br/>Prospective Studies<br/>Pyridines--therapeutic use<br/>Skin Diseases--chemically induced<br/>Sorafenib<br/>Survival Rate<br/>Treatment Outcome<br/>Vomiting--chemically induced